Cancer Care: The Next Generation only on ABC7

WABC logo
Friday, November 4, 2016
Cancer Care The Next Generation
EMBED <>More Videos

Find out about the half hour special airing Saturday, September 17th on ABC7.

NEW YORK (WABC) -- News about Cancer research and breakthroughs are everywhere these days, but how does it affect you? ABC7NY is working closely with the cancer specialists and research labs of New-York Presbyterian Hospital to bring you answers. Voted for the 16th year in a row by US News and World Report as New York's number 1 hospital, we hear from the top cancer doctors in a multitude of specialties about how the fight against cancer is evolving.

Having access to an institution that's a comprehensive medical center combined with two Ivy League Medical Schools (Columbia University and Weill Cornell) gives New Yorkers a distinct advantage if they or a loved one is battling cancer. We'll see how integrated therapies like Reiki and innovations are helping patients cope with the side-effects of cancer treatment. You'll meet residents from our area who had all but given up hope but are now, living testimonials to the strides being made. And of course, the best way to beat cancer is to prevent it. We'll ask the cancer experts for their most important cancer prevention tips.

Our special half hour, "Cancer Care, The Next Generation" is here to be viewed and learned from. And after you watch, scroll down for much more from our experts, including an information-filled web chat.

Part 1:

Part 2:

Part 3:

Part 4:


Experts from NewYork-Presbyterian/Columbia University Medical Center and NewYork-Presbyterian/Weill Cornell Medicine joined our Michelle Charlesworth for a Q&A web chat on innovations in cancer care. You can watch it right here.


Dr. Gary Schwartz is Chief of Hematology and Medical Oncology at NewYork-Presbyterian/Columbia University Medical Center. He is an internationally recognized expert in the treatment of patients with melanoma and sarcoma, and in the area of new drug development. He directs a laboratory which focuses on the identification of new targeted agents for cancer therapy. His research studies have been supported by the National Cancer Institute, the Lustgarten Foundation for Pancreatic Cancer, the Department of Defense for Breast Cancer Research, the Byrne Foundation, and the Food and Drug Administration. Over the course of his career, he has received many awards including the Lustgarten Foundation for Pancreatic Research, Jeannik M. Littlefield - AACR Award in Metastatic Colon Cancer, and the New York State Teaching Award in the Empire Clinical Research Investigator Program.

Dr. David Nanus is Chief of Hematology and Medical Oncology at NewYork-Presbyterian/Weill Cornell Medicine. Dr. Nanus is also Associate Director of Clinical Services for the Sandra and Edward Meyer Cancer Center/Weill Cornell Medicine. He is an internationally recognized leader in the treatment and care of patients with genitourinary (GU) cancers, including cancers of the prostate, kidney, bladder and testes. He is actively involved in clinical, translational and basic research in GU malignancies, serving as principle or co-investigator on a variety of clinical research trials that incorporate novel targeted therapies for his patients. He is the recipient of numerous awards including membership in the American Society for Clinical Investigation and the American Association of Physicians.